329 related articles for article (PubMed ID: 33059738)
1. A novel chemical-combination screen in zebrafish identifies epigenetic small molecule candidates for the treatment of Duchenne muscular dystrophy.
Farr GH; Morris M; Gomez A; Pham T; Kilroy E; Parker EU; Said S; Henry C; Maves L
Skelet Muscle; 2020 Oct; 10(1):29. PubMed ID: 33059738
[TBL] [Abstract][Full Text] [Related]
2. Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy.
Spreafico M; Cafora M; Bragato C; Capitanio D; Marasca F; Bodega B; De Palma C; Mora M; Gelfi C; Marozzi A; Pistocchi A
Pharmacol Res; 2021 Aug; 170():105750. PubMed ID: 34214631
[TBL] [Abstract][Full Text] [Related]
3. High-throughput screening identifies modulators of sarcospan that stabilize muscle cells and exhibit activity in the mouse model of Duchenne muscular dystrophy.
Shu C; Parfenova L; Mokhonova E; Collado JR; Damoiseaux R; Campagna J; John V; Crosbie RH
Skelet Muscle; 2020 Sep; 10(1):26. PubMed ID: 32948250
[TBL] [Abstract][Full Text] [Related]
4. Muscle dysfunction and structural defects of dystrophin-null sapje mutant zebrafish larvae are rescued by ataluren treatment.
Li M; Andersson-Lendahl M; Sejersen T; Arner A
FASEB J; 2014 Apr; 28(4):1593-9. PubMed ID: 24371125
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors: a potential epigenetic treatment for Duchenne muscular dystrophy.
Consalvi S; Saccone V; Mozzetta C
Epigenomics; 2014; 6(5):547-60. PubMed ID: 25431946
[TBL] [Abstract][Full Text] [Related]
6. Givinostat as metabolic enhancer reverting mitochondrial biogenesis deficit in Duchenne Muscular Dystrophy.
Giovarelli M; Zecchini S; Catarinella G; Moscheni C; Sartori P; Barbieri C; Roux-Biejat P; Napoli A; Vantaggiato C; Cervia D; Perrotta C; Clementi E; Latella L; De Palma C
Pharmacol Res; 2021 Aug; 170():105751. PubMed ID: 34197911
[TBL] [Abstract][Full Text] [Related]
7. Determinants of epigenetic resistance to HDAC inhibitors in dystrophic fibro-adipogenic progenitors.
Consalvi S; Tucciarone L; Macrì E; De Bardi M; Picozza M; Salvatori I; Renzini A; Valente S; Mai A; Moresi V; Puri PL
EMBO Rep; 2022 Jun; 23(6):e54721. PubMed ID: 35383427
[TBL] [Abstract][Full Text] [Related]
8. Development of a high-throughput screen to identify small molecule enhancers of sarcospan for the treatment of Duchenne muscular dystrophy.
Shu C; Kaxon-Rupp AN; Collado JR; Damoiseaux R; Crosbie RH
Skelet Muscle; 2019 Dec; 9(1):32. PubMed ID: 31831063
[TBL] [Abstract][Full Text] [Related]
9. The HDAC Inhibitor TSA Ameliorates a Zebrafish Model of Duchenne Muscular Dystrophy.
Johnson NM; Farr GH; Maves L
PLoS Curr; 2013 Sep; 5():. PubMed ID: 24459606
[TBL] [Abstract][Full Text] [Related]
10. HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients.
Mozzetta C; Sartorelli V; Steinkuhler C; Puri PL
Trends Mol Med; 2024 Mar; 30(3):278-294. PubMed ID: 38408879
[TBL] [Abstract][Full Text] [Related]
11. Quantification of birefringence readily measures the level of muscle damage in zebrafish.
Berger J; Sztal T; Currie PD
Biochem Biophys Res Commun; 2012 Jul; 423(4):785-8. PubMed ID: 22713473
[TBL] [Abstract][Full Text] [Related]
12. The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene.
Licandro SA; Crippa L; Pomarico R; Perego R; Fossati G; Leoni F; Steinkühler C
Skelet Muscle; 2021 Jul; 11(1):19. PubMed ID: 34294164
[TBL] [Abstract][Full Text] [Related]
13. Drug screening in a zebrafish model of Duchenne muscular dystrophy.
Kawahara G; Karpf JA; Myers JA; Alexander MS; Guyon JR; Kunkel LM
Proc Natl Acad Sci U S A; 2011 Mar; 108(13):5331-6. PubMed ID: 21402949
[TBL] [Abstract][Full Text] [Related]
14. The SINE Compound KPT-350 Blocks Dystrophic Pathologies in DMD Zebrafish and Mice.
Hightower RM; Reid AL; Gibbs DE; Wang Y; Widrick JJ; Kunkel LM; Kastenschmidt JM; Villalta SA; van Groen T; Chang H; Gornisiewicz S; Landesman Y; Tamir S; Alexander MS
Mol Ther; 2020 Jan; 28(1):189-201. PubMed ID: 31628052
[TBL] [Abstract][Full Text] [Related]
15. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
[TBL] [Abstract][Full Text] [Related]
16. Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo.
Bassett DI; Bryson-Richardson RJ; Daggett DF; Gautier P; Keenan DG; Currie PD
Development; 2003 Dec; 130(23):5851-60. PubMed ID: 14573513
[TBL] [Abstract][Full Text] [Related]
17. PDE10A Inhibition Reduces the Manifestation of Pathology in DMD Zebrafish and Represses the Genetic Modifier PITPNA.
Lambert MR; Spinazzola JM; Widrick JJ; Pakula A; Conner JR; Chin JE; Owens JM; Kunkel LM
Mol Ther; 2021 Mar; 29(3):1086-1101. PubMed ID: 33221436
[TBL] [Abstract][Full Text] [Related]
18. Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies.
Sandonà M; Cavioli G; Renzini A; Cedola A; Gigli G; Coletti D; McKinsey TA; Moresi V; Saccone V
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901738
[TBL] [Abstract][Full Text] [Related]
19. Muscle dysfunction in a zebrafish model of Duchenne muscular dystrophy.
Widrick JJ; Alexander MS; Sanchez B; Gibbs DE; Kawahara G; Beggs AH; Kunkel LM
Physiol Genomics; 2016 Nov; 48(11):850-860. PubMed ID: 27764767
[No Abstract] [Full Text] [Related]
20. Nutraceutical Screening in a Zebrafish Model of Muscular Dystrophy: Gingerol as a Possible Food Aid.
Licitra R; Marchese M; Brogi L; Fronte B; Pitto L; Santorelli FM
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33808773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
